Complete Home Health Of Western Oklahoma Location: 1109 Wcherry Street, Enid, Oklahoma 73703 Ratings: Phone: (580) 237-1819 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Integris Home Care Enid Location: 401 South 3rd, Enid, Oklahoma 73701 Ratings: Phone: (580) 548-1116 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Healthback Of Enid Location: 310 South 4th, Suite B, Enid, Oklahoma 73701 Ratings: Phone: (580) 233-4217 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Elara Caring V Location: 427 E Cherokee Ave, Suite 3, Enid, Oklahoma 73701 Ratings: Phone: (580) 213-3334 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
News Archive
With prescription drug abuse at epidemic levels nationwide, and overdoses killing more people than auto accidents in many states, a new University of Michigan study provides striking new data about the misuse of potent prescription painkillers and sedatives by teens and young adults.
UNAIDS and PEPFAR on Monday at the 16th International Conference on AIDS and Sexually Transmitted Infections (STIs) in Africa (ICASA) "launched a five-year action framework to accelerate the scale-up of voluntary medical male circumcision (VMMC) for HIV prevention," according to a UNAIDS press release.
Funding has been granted for research seeking the best care options for patients with leukaemia and other blood disorders and their families.
The NIH is expected on February 1 to release a statement explaining how the U.S. National Science Advisory Board for Biosecurity (NSABB) reached a decision late last year to recommend "that two scientific papers describing research that created strains of bird flu potentially transmissible in humans should be published only if key details are omitted," for fear "that terrorists or hostile nations could learn how to cause a pandemic," a New York Times editorial by Philip Boffey, Times science editorial writer, states.
Following an innovative, years long advocacy campaign spearheaded by AIDS Healthcare Foundation (AHF) that targeted Merck and Co. Pharmaceuticals over the pricing of its AIDS drug Isentress—one of the most expensive first line AIDS therapies on the US market today—officials from AHF lauded Merck today for significant concessions that the drug giant is putting in place on its pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAP), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.
› Verified 8 days ago